Early findings show new drug could be ‘gamechanging’ for brain cancer treatment

Using ipatasertib, researchers say some brain cancers could potentially be made vulnerable to immunotherapy agent

Two people with advanced brain cancer of the sort that led to the death of the MP Tessa Jowell have responded well in a small trial to an experimental combination of chemo and immunotherapy drugs. In one case, the life-threatening tumour seems to have disappeared.

Doctors at the Institute of Cancer Research and the Royal Marsden hospital in London cautioned that this was very early research but said it was unusual to have such a good response in patients in an early trial.

Continue reading…

Leave a comment

Your email address will not be published. Required fields are marked *